Structure and function of S-adenosylhomocysteine hydrolase

被引:156
|
作者
Turner, MA
Yang, XD
Yin, D
Kuczera, K
Borchardt, RT
Howell, PL
机构
[1] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[2] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA
[3] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA
[4] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA
[5] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON M5S 1A8, Canada
关键词
adenosine (Ado); ado kinase(AK); homocysteine (Hcy); neplanocin A (Nep A); S-adenosylhomocysteine (AdoHcy); S-adenosylhomocysteine hydrolase (AdoHcyase); transmethylations;
D O I
10.1385/CBB:33:2:101
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In mammals, S-adenosylhomocysteine hydrolase (AdoHcyase) is the only known enzyme to catalyze the breakdown of S-adenosylhomocysteine (AdoHcy) to homocysteine and adenosine. AdoHcy is the product of all adenosylmethionine (AdoMet)-dependent biological transmethylations. These reactions have a wide range of products, and are common in all facets of biometabolism. As a product inhibitor, elevated levels of AdoHcy suppress AdoMet-dependent transmethylations. Thus, AdoHcyase is a regulator of biological transmethylation in general. The three-dimensional structure of AdoHcyase complexed with reduced nicotinamide adenine dinucleotide phosphate (NADH) and the inhibitor (1'R, 2'5, 3'R)-9- (2',3'-dihyroxycydopenten-1-yl)adenine (DHCeA) was solved by a combination of the crystallographic direct methods program, SnB, to determine the selenium atom substructure and by treating the multiwavelength anomalous diffraction data as a special case of multiple isomorphous replacement. The enzyme architecture resembles that observed for NAD-dependent dehydrogenases, with the catalytic domain and the cofactor-binding domain each containing a modified Rossmann fold. The two domains form a deep active site cleft containing the cofactor and bound inhibitor molecule. A comparison of the inhibitor complex of the human enzyme and the structure of the rat enzyme, solved without inhibitor, suggests that a 17 degrees rigid body movement of the catalytic domain occurs upon inhibitor/substrate binding.
引用
收藏
页码:101 / 125
页数:25
相关论文
共 50 条
  • [21] Biological effects of inhibitors of S-adenosylhomocysteine hydrolase
    Chiang, PK
    PHARMACOLOGY & THERAPEUTICS, 1998, 77 (02) : 115 - 134
  • [22] Inhibition of S-adenosylhomocysteine hydrolase by acyclic sugar adenosine analogue D-eritadenine -: Crystal structure of S-adenosylhomocysteine hydrolase complexed with D-eritadenine
    Huang, YF
    Komoto, J
    Takata, Y
    Powell, DR
    Gomi, T
    Ogawa, H
    Fujioka, M
    Takusagawa, F
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (09) : 7477 - 7482
  • [23] S-ADENOSYLMETHIONINE, S-ADENOSYLHOMOCYSTEINE AND S-ADENOSYLHOMOCYSTEINE HYDROLASE VARIATIONS DURING DIFFERENTIATION OF DICTYOSTELIUM-DISCOIDEUM
    GUITTON, MC
    KELLER, BT
    PART, D
    DEGUNZBURG, J
    BORCHARDT, RT
    VERON, M
    CELL DIFFERENTIATION, 1988, 22 (03): : 203 - 210
  • [24] S-Adenosylhomocysteine hydrolase deficiency - a review of nine patients
    Baric, Ivo
    Cuk, Mario
    Petkovic-Ramadza, Danijela
    Bilic, Karmen
    Zibar, Karin
    Sarnavka, Vladimir
    Vugrek, Oliver
    Burlina, Alberto
    Mudd, S. Harvey
    Fumic, Ksenija
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (03) : 303 - 303
  • [25] TRUNCATED FLUOROCYCLOPENTENYL PYRIMIDINES AS S-ADENOSYLHOMOCYSTEINE HYDROLASE INHIBITORS
    Park, Yeon Hee
    Choi, Won Jun
    Tipnis, Arnol S.
    Lee, Kang Man
    Jeong, Lak Shin
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2009, 28 (5-7): : 601 - 613
  • [26] LIMITED PROTEOLYSIS OF S-ADENOSYLHOMOCYSTEINE HYDROLASE - IMPLICATIONS FOR THE 3-DIMENSIONAL STRUCTURE
    GUPTA, RA
    YUAN, CS
    AULTRICHE, DB
    BORCHARDT, RT
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 319 (02) : 365 - 371
  • [27] S-adenosylhomocysteine hydrolase as a target for intracellular adenosine action
    Kloor, D
    Osswald, H
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (06) : 294 - 297
  • [28] INTERFERENCE WITH THYMOCYTE DIFFERENTIATION BY AN INHIBITOR OF S-ADENOSYLHOMOCYSTEINE HYDROLASE
    BENVENISTE, P
    ZHU, W
    COHEN, A
    JOURNAL OF IMMUNOLOGY, 1995, 155 (02): : 536 - 544
  • [29] Nucleoside inhibitors of S-adenosylhomocysteine hydrolase as antimalarial compounds
    Chiang, PK
    Ellis, WY
    Gordon, RK
    Scovill, JP
    Kyle, DE
    FASEB JOURNAL, 1997, 11 (09): : A1273 - A1273
  • [30] Asymptomatic pediatric presentation of S-adenosylhomocysteine hydrolase deficiency
    Pinto, Patricia Lipari
    Dixon, Marjorie
    Sudhakar, Sniya
    Baric, Ivo
    Baruteau, Julien
    JIMD REPORTS, 2024, 65 (06): : 371 - 381